Jul 15, 2020 · Minimal residual disease (MRD) is common in patients with blood cancers, such as leukemia, lymphoma and multiple myeloma. But what does this mean for patients and their need for …

Minimal residual disease (MRD), also known as molecular residual disease, or measurable residual disease, is the medical condition in which small number of cancer cells persist in a patient either …

4 days ago · CURE spoke with Dr. Dickran Kazandjian about why MRD matters for patients with multiple myeloma. During the 2025 American Society of Hematology annual meeting, held earlier this month …

Mar 17, 2022 · Learn all about minimal residual disease (MRD), how doctors test for it, what your results may mean, and what you can do next.

Aug 13, 2025 · Minimal Residual Disease (MRD), also called measurable residual disease, refers to the small population of malignant cells that remain after treatment and are undetectable by conventional …

Jul 1, 2025 · Learn how physicians use this crucial tool in modern oncology to improve patient outcomes. Minimal residual disease (MRD) testing is a critical tool for assessing the long-term …

Apr 8, 2025 · MRD refers to the small number of cancer cells that may remain in the body after treatment, even when imaging shows no signs of disease. These cells, called disseminated tumor …